AVR Distribution by Age, Cusp, and CAD Data 932 consecutive AVR patients 1993–2004 Roberts, Circulation. 2005; 111:920–925.

Slides:

Advertisements

Similar presentations

Slide Gallery Simple Slide Format AvA Aortic Valve Bypass Graft System.

Advertisements

Types of AVR Examples of replacement aortic valves: a) shows an aortic homograft, b) and c) show a xenograft, d) shows a ball and cage valve, e) shows.

Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.

A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.

PARTNER Objective To compare surgical aortic valve replacement (AVR) with transcatheter aortic valve replacement (TAVR) in high-risk patients with severe.

Simultaneous Sessions: Congenital Heart Disease

Trancatheter Aortic Valve Implantation (TAVI)

European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: AACVPR/ACC/AHA 2007 Performance Measures on Cardiac.

Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.

EXPANDING INDICATIONS OF TRANSCATHETER HEART VALVE INTERVENTIONS. JACC CARDIOVASCULAR INTERVENTION. DR.RAJAT GANDHI.

1 Heart surgery in Norway 2008 Norwegian Association of Cardiothoracic Surgeons Jan L.Svennevig, MD,PhD

© free-ppt-templates.com 2017 AHA/ACC Focused Update of Valvular Heart Disease Guideline of 2014 DR. OMAR SHAHID TR CARDIOLOGY SZH.

David R. Holmes, MD, FACC, Michael J

Jan L.Svennevig, MD,PhD Heart surgery in Norway 2009 Norwegian Association for Cardiothoracic Surgery Jan L.Svennevig, MD,PhD.

Fractional Flow Reserve Evaluation in Patients Considered for Transfemoral Transcatheter Aortic Valve Implantation: A Case Series Cardiology 2012;123:234–239.

David R. Holmes, MD, Michael J

Jan L.Svennevig, MD,PhD Heart surgery in Norway 2005 Norwegian Association of Cardiothoracic Surgeons Jan L.Svennevig, MD,PhD.

TAVI Passed the Exam and is Ready for Clinical Use in Inoperable Patients Disclosures Research Funding and Speaking Honoraria: Edwards Lifesciences.

Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.

Jan L.Svennevig, MD,PhD Heart surgery in Norway 2006 Norwegian Association of Cardiothoracic Surgeons Jan L.Svennevig, MD,PhD.

Successful CTO PCI Associated with Lower Mortality Risk

Choosing the valve type for AVR in old patients.

Jan L.Svennevig, MD,PhD Heart surgery in Norway 2007 Norwegian Association of Cardiothoracic Surgeons Jan L.Svennevig, MD,PhD.

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Late Follow-Up from the PARTNER Aortic Valve-in-Valve Registry

Anticoagulants in Interventional Cardiology:

Richard S. D’Agostino, MD, Jeffrey P

Richard S. D’Agostino, MD, Jeffrey P

Cardiovacular Research Technologies

Surgeon Involvement in Transcatheter Aortic Valve Replacement in the United States: A 2016 Society of Thoracic Surgeons Survey Joseph E. Bavaria, MD,

Reply The Annals of Thoracic Surgery

Coronary Artery Surgery

Jan L.Svennevig, MD,PhD Heart surgery in Norway 2004 Norwegian Association of Cardiothoracic Surgeons Jan L.Svennevig, MD,PhD.

Risk Factors Associated With Reoperation and Mortality in 252 Patients After Aortic Valve Replacement for Congenitally Bicuspid Aortic Valve Disease

David R. Holmes, MD, FACC, Michael J

Johannes Steiner et al. JACC 2017;70:

Johannes Steiner et al. JACC 2017;70:

Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. Aspects to be considered by the.

Figure 4 TAVI for bicuspid aortic valve disease

The surgical and interventional hybrid era: Experiences from China

Richard S. D'Agostino, MD, Jeffrey P

Should We Perform Carotid Doppler Screening Before Surgical or Transcatheter Aortic Valve Replacement? Jose F. Condado, MD, MS, Hanna A. Jensen, MD,

Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,

Coronary revascularisation rate (total 5

The Progression of a Transcatheter Aortic Valve Program: A Decision Analysis of More Than 680 Patient Referrals Joseph E. Bavaria, MD, Wilson Y. Szeto,

Richard S. D’Agostino, MD, Jeffrey P

Three-Dimensional Printing of Models for Preoperative Planning and Simulation of Transcatheter Valve Replacement Daniel Schmauss, MD, Christoph Schmitz,

David R. Holmes, MD, Michael J

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Impact of Transcatheter Technology on Surgical Aortic Valve Replacement Volume, Outcomes, and Cost Robert B. Hawkins, MD, Emily A. Downs, MD, Lily E.

Aortic Valve Replacement and Concomitant Coronary Artery Bypass: Assessing the Impact of Multiple Grafts Kimiyoshi J. Kobayashi, BS, Jason A. Williams,

Dilatation of the Remaining Aorta After Aortic Valve or Aortic Root Replacement in Patients With Bicuspid Aortic Valve: A 5-Year Follow-Up Nada Abdulkareem,

Aortic Valve Bypass for the High-Risk Patient With Aortic Stenosis

The Journal of Thoracic and Cardiovascular Surgery

Conventional redo biological valve replacement over 20 years: Surgical benchmarks should guide patient selection for transcatheter valve-in-valve therapy

Endothelial Nitric Oxide Synthase in Bicuspid Aortic Valve Disease

Markus Liebrich, MD, Marcin K

Successful Neonatal Double Switch in Symptomatic Patients With Congenitally Corrected Transposition of the Great Arteries Victor Bautista-Hernandez,

Paul Urbanski, MD, PhD The Annals of Thoracic Surgery

Root Remodeling and Aortic Valve Repair for Unicuspid Aortic Valve

Racing to the Rubicon Michael J. Reardon, MD, Vinod H. Thourani, MD

Transatlantic editorial: A comparison between European and North American guidelines on myocardial revascularization Philippe Kolh, MD, PhD, Paul Kurlansky,

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Lung Transplantation and Coronary Artery Disease

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Aortic Valve Function After Bicuspidization of the Unicuspid Aortic Valve Diana Aicher, MD, Moritz Bewarder, Michael Kindermann, MD, Hashim Abdul-Khalique,

Michael O. Kayatta, MD, Bradley G

Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation: a propensity score matched analysis Maurizio Taramasso MD, PhD from.

Presentation transcript:

AVR Distribution by Age, Cusp, and CAD Data 932 consecutive AVR patients 1993–2004 Roberts, Circulation. 2005; 111:920–925

Cusp Type and/or CAD Prevalence in AVR pts. over age 70 AVBG Transcatheter Valve Bicuspid w/o CAD20%+ Contraindicated * Bicuspid w/CAD20%+ Contraindicated * Tricuspid w/o CAD21%++ Tricuspid w/ CAD39%+ Contraindicated * Alternative Therapies by Cusp Type and CAD Edwards LifeScience PARTNER Trial protocol European Association of Cardio-Thoracic Surgeons guidelines European Society of Cardiology guidelines * Patients with Bicuspids or Untreated Significant CAD are contraindicated for transcather valve implantaion Future CAD Intervention Bicuspid

Will Transcatheter procedures be applicable to broad market segment? AttributeNo CADCAD Tricuspid 21%39% Bicuspid 20% Key PARTNER Trial Exclusion Criteria: Aortic valve is a congenital unicuspid or bicuspid valve; or is non-calcified Untreated clinically significant coronary artery disease requiring revascularization AVR Patients Age 70+ Data 932 consecutive AVR patients 1993–2004 Roberts, Circulation. 2005; 111:920–925